Delve Insight Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

DelveInsight’s Report, “Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufac...

$ 2000


DelveInsight’s Report, “Thrombocythaemia Myelofibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers...

$ 2000


DelveInsight “Sickle Cell Anemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Sickle Cell Anemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology histor...

$ 2750


DelveInsight’s Report, “Ventricular Arrhythmia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross t...

$ 2000


DelveInsight’s Report, “Thrombocytopenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the glo...

$ 2000


DelveInsight “Thalassemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Thalassemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forec...

$ 2750


DelveInsight’s Report, “Ventricular Tachycardia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross ...

$ 2000


DelveInsight’s Report, “Thrombotic Thrombocytopenic Purpura-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufact...

$ 2000


DelveInsight “Polycythemia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Polycythemia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and for...

$ 2750


DelveInsight’s Report, “Vulval Atrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe...

$ 2000


DelveInsight’s Report, “Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe...

$ 2000


DelveInsight “Primary Biliary Cirrhosis - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Primary Biliary Cirrhosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epide...

$ 2750


DelveInsight’s Report, “Vulvovaginal Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...

$ 2000


DelveInsight’s Report, “Tourette Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the gl...

$ 2000


DelveInsight “Acute Myeloid Leukemia (AML) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute Myeloid Leukemia (AML) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years...

$ 2750


DelveInsight’s Report, “Women Infertility-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the gl...

$ 2000


DelveInsight’s Report, “Type I Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross ...

$ 2000


DelveInsight “Idiopathic pulmonary fibrosis (IPF) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Idiopathic pulmonary fibrosis (IPF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It inc...

$ 2750


DelveInsight’s Report, “Zollinger-Ellison Syndrome (Gastrinoma)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manu...

$ 2000


DelveInsight’s Report, “Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the glo...

$ 2000


DelveInsight “Multiple Myeloma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Multiple Myeloma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical...

$ 2750

Live Chat Support
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from Delve Insight. We have market research reports of all sectors covered by the Delve Insight; you can access and utilize them at economical budgets.

More about our Subscription option